INTRODUCTION: To investigate susceptibility to leprosy reactions, three polymorphisms of the natural resistance-associated macrophage protein (NRAMP1) gene were determined in 201 individuals who were attended at two reference centers in Recife, between 2007 and 2008. Of these, 100 were paucibacillary and 101 were multibacillary. METHODS: The 274C/T, D543N and 1729+55del4 polymorphisms of the NRAMP1 gene were determined using the technique of restriction fragment polymorphism on DNA extracted from peripheral blood. Allelic and genotypic frequencies were estimated by direct counting. RESULTS: The predominant genotypes were: CC (51.8%) for 274C/T; GG (86.6%) for D543N; and +-TGTG (59.9%) for 1729+55del4. The mutant genotype 274 TT predominated in negativity of the reverse reaction (p = 0.03) and in positivity of erythema nodosum leprosum (p = 0.04). CONCLUSIONS: Our results suggest that 274 C/T polymorphism of the NRAMP1 gene may aid in determining the susceptibility to type II reactions among leprosy patients.
INTRODUCTION: To investigate susceptibility to leprosy reactions, three polymorphisms of the natural resistance-associated macrophage protein (NRAMP1) gene were determined in 201 individuals who were attended at two reference centers in Recife, between 2007 and 2008. Of these, 100 were paucibacillary and 101 were multibacillary. METHODS: The 274C/T, D543N and 1729+55del4 polymorphisms of the NRAMP1 gene were determined using the technique of restriction fragment polymorphism on DNA extracted from peripheral blood. Allelic and genotypic frequencies were estimated by direct counting. RESULTS: The predominant genotypes were: CC (51.8%) for 274C/T; GG (86.6%) for D543N; and +-TGTG (59.9%) for 1729+55del4. The mutant genotype 274 TT predominated in negativity of the reverse reaction (p = 0.03) and in positivity of erythema nodosum leprosum (p = 0.04). CONCLUSIONS: Our results suggest that 274 C/T polymorphism of the NRAMP1 gene may aid in determining the susceptibility to type II reactions among leprosypatients.
Authors: Priscila Saamara Mazini; Hugo Vicentin Alves; Pâmela Guimarães Reis; Ana Paula Lopes; Ana Maria Sell; Manuel Santos-Rosa; Jeane Eliete Laguila Visentainer; Paulo Rodrigues-Santos Journal: Front Immunol Date: 2016-01-12 Impact factor: 7.561
Authors: Eileen Png; Bachti Alisjahbana; Edhyana Sahiratmadja; Sangkot Marzuki; Ron Nelwan; Yanina Balabanova; Vladyslav Nikolayevskyy; Francis Drobniewski; Sergey Nejentsev; Iskandar Adnan; Esther van de Vosse; Martin L Hibberd; Reinout van Crevel; Tom H M Ottenhoff; Mark Seielstad Journal: BMC Med Genet Date: 2012-01-13 Impact factor: 2.103
Authors: Stephen L Walker; Marivic Balagon; Joydeepa Darlong; Shimelis N Doni; Deanna A Hagge; Vikas Halwai; Annamma John; Saba M Lambert; Armi Maghanoy; Jose A C Nery; Kapil D Neupane; Peter G Nicholls; Vivek V Pai; Pawan Parajuli; Anna M Sales; Euzenir Sarno; Mahesh Shah; Digafe Tsegaye; Diana N J Lockwood Journal: PLoS Negl Trop Dis Date: 2015-09-09
Authors: N Lucena-Silva; M A G Teixeira; A de L Ramos; R S de Albuquerque; G T N Diniz; C T Mendes-Junior; E C Castelli; E A Donadi Journal: Mol Genet Genomic Med Date: 2013-06-07 Impact factor: 2.183
Authors: Maria José Franco Brochado; Maria Fernanda Chociay Gatti; Marco Antônio Zago; Ana Maria Roselino Journal: Mem Inst Oswaldo Cruz Date: 2016-01-26 Impact factor: 2.743